Retinoic Acid Receptor beta Antikörper
Kurzübersicht für Retinoic Acid Receptor beta Antikörper (ABIN6337082)
Target
Alle Retinoic Acid Receptor beta (RARB) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
-
WB, IHC, IF/ICC, WB: 0.5-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml.
Optimal dilutions/concentrations should be determined by the end user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for up to one year. Avoid repeated freeze/thaw cycles.
-
-
- Retinoic Acid Receptor beta (RARB) (Retinoic Acid Receptor, beta (RARB))
-
Andere Bezeichnung
- Retinoic Acid Receptor Beta
-
Pathways
- Nuclear Receptor Transcription Pathway, Retinoic Acid Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway
Target
-